# Therapeutic Monitoring of Drugs Used in the Treatment of Multiple Sclerosis

> **NCT05112484** · — · NOT_YET_RECRUITING · sponsor: **University Hospital Ostrava** · enrollment: 600 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DIAGNOSTIC_TEST:** Measurement of concentrations of orally-used DMDs
- **DIAGNOSTIC_TEST:** Genetic testing
- **DIAGNOSTIC_TEST:** Parameters for routine use of DMDs
- **OTHER:** Side effects of orally used DMDs

## Key facts

- **NCT ID:** NCT05112484
- **Lead sponsor:** University Hospital Ostrava
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06
- **Primary completion:** 2025-11
- **Final completion:** 2026-05
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05112484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05112484, "Therapeutic Monitoring of Drugs Used in the Treatment of Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05112484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*